A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EFFICACY AND SAFETY STUDY OF PITOLISANT FOLLOWED BY AN OPEN-LABEL EXTENSION IN PATIENTS WITH PRADERWILLI SYNDROME

Registry ID

HBS-101-CL-312

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE3

Study type

INTERVENTIONAL

Sponsor

HARMONY BIOSCIENCES MANAGEMENT, INC.

Start date

2025-05-30

Last update

2025-04-24

Conditions

• PRADER-WILLI SYNDROME

Related clinical trials

• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ARD-101 FOR THE TREATMENT OF HYPERPHAGIA IN PATIENTS WITH PRADER -WILLI SYNDROME

View on source registry